EPISODE · Mar 12, 2024 · 26 MIN
Duopharma Seeking To Diversify Manufacturing Domain
from The Breakfast Grille · host BFM Media
Malaysian pharmaceutical Duopharma Biotech achieved their best financial performance to date in 2022, reaching record highs for revenue and profit. However 2023 was not as kind, with profit after tax falling by 25% despite top line growth. How are they looking to reverse course in 2024? We discuss strategy with Group Managing Director Leonard Ariff Abdul Shatar.See omnystudio.com/listener for privacy information.
NOW PLAYING
Duopharma Seeking To Diversify Manufacturing Domain
No transcript for this episode yet
Similar Episodes
No similar episodes found.